Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
5.21
-0.45 (-7.88%)
At close: Jul 3, 2025, 4:00 PM
5.11
-0.09 (-1.83%)
Pre-market: Jul 7, 2025, 4:34 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $27.81 million as of July 7, 2025. Its market cap has increased by 246.23% in one year.
Market Cap
27.81M
Enterprise Value
21.68M
1-Year Change
246.23%
Ranking
Category
Stock Price
$5.21
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $27.81M, a decrease of -91.40%. That is a compound annual growth rate of -49.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 27.81M | 197.73% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |